Demonstration of in vitro antagonism between Aztreonam and third generation cephalosporins and imipenem
Tarrand, J.; Pai, S.; Buckner, M.; Rolston, K.
Abstracts of the General Meeting of the American Society for Microbiology 95: 153
1995
ISSN/ISBN: 1060-2011 Accession: 030823371
PDF emailed within 1 workday: $29.90
Related References
Zemelman, R.; Bello, H.; Dominguez, M.; Gonzalez, G.; Mella, S.; Garcia, A. 1993: Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals Journal of Antimicrobial ChemoTherapy 32(3): 413-419Ennis, D.M.; Cobbs, C.G. 1995: The newer cephalosporins. Aztreonam and imipenem Infectious Disease Clinics of North America 9(3): 687-713
Charak, B.S.; Louie, R.; Malloy, B.; Twomey, P.; Mazumder, A. 1991: The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity Journal of Antimicrobial ChemoTherapy 27(1): 95-104
Miller, M.A.; Finan, M.; Yousuf, M. 1983: In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens Journal of Antimicrobial ChemoTherapy 11(4): 311-318
Hammer, L.; Gornick, W.; Shigei, J.; Hamm Hayden, P.; Taggart, J.; Waxman, K.; Thrupp, L. 1991: Increased use of aztreonam az and 3rd generation cephalosporins 3ce associated with emergence of resistant r enterobacter cloacae ec and acinetobacter anitratum aa Abstracts of the General Meeting of the American Society for Microbiology 91: 424
Del Rosario Valencia, A.M.; Vuye, A.; Pijck, J. 1984: Selection of resistant mutants of citrobacter freundii by 2nd and 3rd generation cephalosporins and imipenem Infection 12(6): 402-406
del Rosario Valencia, A.M.; Vuye, A.; Pijck, J. 1984: Selection of resistant mutants of Citrobacter freundii by second and third-generation cephalosporins and imipenem Infection 12(6): 402-404
Digranes, A.; Dibb, W.L.; Benonisen, E.; Salveson, A. 1985: Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin ChemoTherapy 31(4): 279-285
Bert, F.; Bialek-Davenet, S.; Leflon-Guibout, V.; Noussair, L.; Nicolas-Chanoine, M.-H. 2014: Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam Medecine et Maladies Infectieuses 44(2): 76-78
Babálová, M.; Blahová, J.; Králiková, K.; Krcméry, V.; Hanzen, J.; Balogová, O.; Milosovic, P. 1999: Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases Epidemiologie Mikrobiologie Imunologie: Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne 48(1): 21-27
Buré, A.; Legrand, P.; Arlet, G.; Jarlier, V.; Paul, G.; Philippon, A. 1988: Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 7(6): 780-782
Ho, H.; Zuckerman, M.J.; Norte, A.; Guerra, L.G.; Cortes, E.; Al Samman, M.; Verghese, A. 1993: A comparative study of imipenem-cilastatin and third generation cephalosporins in the treatment of spontaneous bacterial peritonitis Gastroenterology 104(4 Suppl): A916
Powell, M.; Williams, J.D. 1987: In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae Antimicrobial Agents and ChemoTherapy 31(12): 1871-1873
Nemes, G.; Stolle, D.; Nemes, P. 1987: In vitro activity of ciprofloxacin in comparison with aztreonam, imipenem, and ceftazidime against multiply resistant strains Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 133-135
Wang Xiaotao, Lei Zhengzhi; Ju Changde 1996: Postantibiotic effects of ciprofloxacin, ceftazidime, cefminox, aztreonam, imipenem/cilastatin and netilmicin in vitro Zhongguo Kangshengsu Zazhi 21(3): 220-224